Until now, the widely accepted wisdom in the US tech world was that American tech giants could stay ahead by spending billions of dollars, amassing advanced chips and building out huge data centers (despite the environmental cost). Essentially, because they’re among the richest companies in the world, they believed they could throw more resources at the problem than anyone else and come out on top. Now, all of that has been called into question. And tech giants are facing tough questions from Wall Street.
Funded by Tampa General Hospital and The McNamara Foundation, the indoor structure is a clinic-in-a-box that can be installed anywhere there is an outlet. It allows residents to have real-time consultations with a licensed clinician via high-definition audio-video capabilities and a comprehensive suite of medical devices.
University of Missouri researchers and collaborators have developed a new chemical tool that could help lower the cost of prescription medications. The tool, called AshPhos, is a ligand, or molecule, that makes it easier to create special carbon-nitrogen bonds. These bonds are the backbone of more than half of all medicines on the market today.
DeepSeek, a Chinese AI startup that’s just over a year old, has stirred awe and consternation in Silicon Valley after demonstrating breakthrough artificial-intelligence models that offer comparable performance to the world’s best chatbots at seemingly a fraction of the cost.